Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Return on Assets: 2020-2025

Historic Return on Assets for Apellis Pharmaceuticals (APLS) over the last 5 years, with Sep 2025 value amounting to 0.05%.

  • Apellis Pharmaceuticals' Return on Assets rose 32.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.24% for FY2024, which is 45.00% up from last year.
  • As of Q3 2025, Apellis Pharmaceuticals' Return on Assets stood at 0.05%, which was up 117.07% from -0.28% recorded in Q2 2025.
  • Over the past 5 years, Apellis Pharmaceuticals' Return on Assets peaked at 0.05% during Q3 2025, and registered a low of -1.06% during Q4 2021.
  • Its 3-year average for Return on Assets is -0.43%, with a median of -0.38% in 2024.
  • Per our database at Business Quant, Apellis Pharmaceuticals' Return on Assets tumbled by 78bps in 2021 and then surged by 44bps in 2024.
  • Apellis Pharmaceuticals' Return on Assets (Quarterly) stood at -1.06% in 2021, then increased by 26bps to -0.80% in 2022, then grew by 14bps to -0.66% in 2023, then skyrocketed by 44bps to -0.22% in 2024, then surged by 32bps to 0.05% in 2025.
  • Its Return on Assets stands at 0.05% for Q3 2025, versus -0.28% for Q2 2025 and -0.26% for Q1 2025.